Skip to main content

Month: March 2023

Miromatrix Medical Inc. Announces Proposed Public Offering of Common Stock

EDEN PRAIRIE, Minn., March 07, 2023 (GLOBE NEWSWIRE) — Miromatrix Medical Inc. (“Miromatrix”) (Nasdaq: MIRO), a life sciences company pioneering a novel technology for bioengineering fully transplantable organs to help save and improve patients’ lives, today announced that it has commenced an underwritten public offering of shares of its common stock. In connection with the offering, Miromatrix intends to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of its common stock offered in the offering at the public offering price, less underwriting discounts and commissions. All of the shares in the offering are to be sold by Miromatrix. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual...

Continue reading

Chinook Therapeutics to Present at the Oppenheimer 33rd Annual Healthcare Conference

SEATTLE, March 07, 2023 (GLOBE NEWSWIRE) — Chinook Therapeutics, Inc. (Nasdaq: KDNY), a biopharmaceutical company focused on the discovery, development and commercialization of precision medicines for kidney diseases, today announced that Chinook management is scheduled to participate in a virtual fireside chat at the Oppenheimer 33rd Annual Healthcare Conference on Tuesday, March 14, 2023 at 3:20 pm ET, as well as 1×1 meetings. To access the live webcast and subsequent archived recording of this and other company presentations, please visit the Investors section of Chinook’s website. The archived webcast will remain available for replay on Chinook’s website for 90 days. About Chinook Therapeutics, Inc.Chinook Therapeutics, Inc. is a clinical-stage biopharmaceutical company developing precision medicines for kidney diseases....

Continue reading

Blue Line Protection Group Appoints new Director

Denver, CO, March 07, 2023 (GLOBE NEWSWIRE) — Dan Allen, Chief Executive Officer of Blue Line Protection Group (OTCQB: BLPG), is pleased to announce the appointment of Andrew Berman as a Director. “Andrew is a versatile executive with a unique background and skill set. He has extensive cannabis experience, including being CEO of Harborside Inc. (CA), which he took public on the Canadian Securities Exchange in 2019, as well as cannabis start-up operations in Hawaii and Ohio. Andrew also has broad government relations experience having served two terms as Mayor for the City of Mill Valley, California. We are looking forward to having him on our board.” Andrew states “I am very excited to be joining the Board of Blue Line Protection Group. This is a unique opportunity to work with a business that has now expanded...

Continue reading

Toll Brothers Announces New Luxury Home Community Coming Soon to Florida’s West Coast

Monterey at Lakewood Ranch will open for sales in summer 2023Monterey at Lakewood Ranch by Toll Brothers Toll Brothers announced its newest luxury home community, Monterey at Lakewood Ranch in Lakewood Ranch, Florida, opening in summer 2023.Monterey at Lakewood Ranch by Toll Brothers “With floor plans designed for today’s buyers and unrivaled personalization options offered on-site, Monterey at Lakewood Ranch will offer residents the best in luxury living in one of Sarasota County’s most desirable communities,”said Brian O’Hara, Division President of Toll Brothers in Tampa/Sarasota.LAKEWOOD RANCH, Fla., March 07, 2023 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced its newest community of luxury homes, Monterey at Lakewood Ranch, is coming soon to the desirable...

Continue reading

BioCorRx Announced Interim Positive Safety and Pharmacokinetic Results of Phase 1 Clinical Trial at 4th Annual NIH HEAL Initiative Investigator Meeting

BICX104 was Well Tolerated with No Serious Adverse Events Reported and Achieved 84 Days of Therapeutic Naltrexone Plasma Concentrations BICX104 Subjects Experienced Better 84-Day Treatment Adherence Than Vivitrol® Subjects Company Seeking FDA Approval for Immediate Expanded Access “Compassionate Use” of BICX104 for Over 10 Million Americans with Opioid Use Disorder BioCorRx Applying for Fast Track Designation and Also Seeking FDA Pre-NDA Meeting to Confirm Final Pathway for Regulatory ApprovalANAHEIM, CA, March 07, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – BioCorRx Inc. (OTCQB:  BICX) (the “Company”), a clinical-stage developer and provider of innovative treatment programs for substance use and related disorders, has announced interim positive safety and pharmacokinetic (PK) results for the Phase I clinical trial of the Company’s...

Continue reading

Ebix Hosts Q4 Investor Call Wednesday, March 15, 2023 at 11:00 a.m. ET

JOHNS CREEK, Ga., March 07, 2023 (GLOBE NEWSWIRE) — Ebix, Inc. (NASDAQ: EBIX), a leading international supplier of on-demand software and e-commerce services to the insurance, financial services, travel, healthcare and e-learning industries, today announced that the Company will report its 2022 fourth quarter and full year results on Wednesday, March 15, 2023, and will host an investor conference call at 11:00 am ET on the same day to discuss the Company’s performance. The call is open to the public. Conference Call, Webcast and Replay Details:Call Date/Time: March 15, 2023 at 11:00 a.m. ET   US & Canada Toll Free: +1 (800) 715-9871   Call ID: # 2396483   Audio Webcast: https://edge.media-server.com/mmc/p/kodfrx33   Replay URL: https://www.ebix.com/investorhomeAbout Ebix, Inc.With approximately...

Continue reading

Tek84 Inc. Announces Acquisition of IDSS Corp.

Combination Expands Tek84’s High Technology X-ray Security Scanning Solutions SAN DIEGO, March 07, 2023 (GLOBE NEWSWIRE) — High technology security screening and surveillance pioneer Tek84 Inc. announced today the acquisition of Integrated Defense and Security Solutions (IDSS) Corp., a global leader in airport scanner technology. Financial terms were not disclosed. Tek84 develops and manufactures ultra-low-dose x-ray scanning solutions that detect threats – weapons, drugs and other contraband – hidden under clothing, within body cavities and inside vehicles, packages, walls and objects. Tek84 systems are deployed worldwide in jails, prisons and other detention centers, airports, embassies, court houses, border crossings, event venues and critical infrastructure. IDSS combines advanced AI algorithms and high resolution, three-dimensional...

Continue reading

Van Lanschot Kempen promoted to the AMX index and included in the AEX ESG index

Amsterdam/’s-Hertogenbosch in the Netherlands, 7 March 2023 Van Lanschot Kempen will enter the Euronext AMX index and the AEX ESG index as of March 17, 2023 COB. Jeroen Kroes, Chief Financial Officer Van Lanschot Kempen: “The inclusion in both the Midkap index and the AEX ESG index underlines the growth achieved by Van Lanschot Kempen in recent years and our sustainable profile. This will further strengthen our visibility towards investors and is expected to increase liquidity in our stock. At the same time our focus remains unchanged: providing unique, personalised services to our clients. Strategically, we remain focused on sustainable profitable growth, both organically and through acquisitions, with a capital-light balance sheet.” The composition of the Midkap index is reviewed annually in March by Euronext Amsterdam on the basis of...

Continue reading

Geomega Announces $3M in Funding from Government of Canada’s Critical Minerals Research, Development and Demonstration Program

MONTREAL, March 07, 2023 (GLOBE NEWSWIRE) — Geomega Resources Inc. (“Geomega” or the “Corporation”) (TSX.V: GMA) (OTC: GOMRF), a developer of clean and alternative technologies for the extraction, refining, and recycling of rare earths and other critical materials, is pleased to announce that it is receiving $3M in funding from the Government of Canada’s Critical Minerals Research, Development and Demonstration (CMRDD) Program, administered by Natural Resources Canada (NRCan), towards the construction of the magnet recycling demonstration plant. The Government of Canada is investing in the development of Canadian critical minerals value chains that will contribute to Canada’s goal of being a net-zero emitter of carbon by 2050. These critical minerals are essential inputs for renewable energy and clean technology applications such...

Continue reading

Search Minerals to Receive $5 Million in funding from the Government of Canada under the Critical Minerals Research Development & Demonstration Program

VANCOUVER, British Columbia, March 07, 2023 (GLOBE NEWSWIRE) — Search Minerals Inc. (“Search Minerals”) (TSXV: SMY | OTCQB: SHCMF) is pleased to announce that the Government of Canada has contributed $5 million in non-dilutive support to Search Minerals via a Contribution Agreement which will be used to fund the construction and operation of a demonstration plant for rare earth extraction and recovery. The total project cost is estimated at approximately $9.3 million with a further $1 million of funding under application from other sources. Search Minerals’ contribution to the construction costs is expected to be approximately $3.3 million. The demonstration plant will process ~20 tonnes of rare earth concentrate prepared from 72 tonnes of Deep Fox and Foxtrot mineralization using Wet High Intensity Magnetic Separation (Search...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.